المؤلفون: Chen Hu, Wei Fu, Jonathan Hayman, Kai Ding, Ronan J. Kelly, Kristen A. Marrone, Jarushka Naidoo, Valerie Peterson, Sarah Z. Hazell, Salem Alfaifi, Patrick M. Forde, Christine L. Hann, Karthik Suresh, David S. Ettinger, Josephine Feliciano, Cheng Ting Lin, Khinh Ranh Voong, Russell K. Hales, Julie R. Brahmer, Benjamin Levy

المصدر: Clin Lung Cancer

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Subset Analysis, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Pembrolizumab, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, Article, 03 medical and health sciences, symbols.namesake, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Stage (cooking), Lung cancer, Fisher's exact test, Aged, Neoplasm Staging, Pneumonitis, Aged, 80 and over, business.industry, Antibodies, Monoclonal, Cancer, Pneumonia, Middle Aged, medicine.disease, Survival Analysis, Radiation therapy, Nivolumab, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, symbols, Female, Radiology, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14ffb130269faa063812aca10089a8d5Test
https://doi.org/10.1016/j.cllc.2019.02.018Test

المؤلفون: Xue Wu, Xingyang Xue, Misako Nagasaka, Huaxin Ding, Xingsheng Hu, Hui Xia, Qiuxiang Ou, Yang W. Shao, Sai-Hong Ignatius Ou

المصدر: Clinical lung cancer. 21(3)

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Adult, Male, Cancer Research, Lung Neoplasms, Oncogene Proteins, Fusion, Tropomyosin 3, LMNA, 03 medical and health sciences, Exon, 0302 clinical medicine, Sequestosome 1, BCL9, Carcinoma, Non-Small-Cell Lung, Biomarkers, Tumor, Medicine, Humans, Receptor, trkA, education, Sarcomatoid carcinoma, Lung cancer, Protein Kinase Inhibitors, Aged, Retrospective Studies, education.field_of_study, business.industry, Middle Aged, medicine.disease, Prognosis, ErbB Receptors, 030104 developmental biology, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Mutation, Cancer research, Adenocarcinoma, Female, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6054fb3bfdde95e61c12e7fbc6a3a94eTest
https://pubmed.ncbi.nlm.nih.gov/31761448Test

المؤلفون: Jung Oh Kim, Ie Ryung Yoo, Suk Hee Hong, Sang Hoon Chun, Seung Joon Kim, Young Kyoon Kim, Jieun Lee, Jin Hyoung Kang, Chan Kwon Jung, Eun Kyung Jeon, Yeon Shil Kim, Woo Hee Choi

المصدر: Clinical Lung Cancer. 15:e13-e21

مصطلحات موضوعية: Adult, Male, Pulmonary and Respiratory Medicine, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Standardized uptake value, Multimodal Imaging, Gastroenterology, Immunoenzyme Techniques, chemistry.chemical_compound, Fluorodeoxyglucose F18, Internal medicine, Lactate dehydrogenase, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, Medicine, Lung cancer, Etoposide, Aged, Neoplasm Staging, Aged, 80 and over, Cisplatin, Glucose Transporter Type 1, business.industry, Hazard ratio, Glucose transporter, Chemoradiotherapy, Middle Aged, Hypoxia-Inducible Factor 1, alpha Subunit, Prognosis, medicine.disease, Small Cell Lung Carcinoma, Primary tumor, Survival Rate, Proto-Oncogene Proteins c-bcl-2, Oncology, chemistry, Positron-Emission Tomography, Female, Radiopharmaceuticals, Tomography, X-Ray Computed, business, Nuclear medicine, Follow-Up Studies, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eed55d9a5e92a28daa138029af90069dTest
https://doi.org/10.1016/j.cllc.2013.09.005Test

المؤلفون: Elaine W. Kay, Lydia Forde, Robert Cummins, Sinead Cuffe, Kathy Gately, Kenneth J. O'Byrne, Friedrich Feuerhake

المصدر: Clinical Lung Cancer. 15:58-66

مصطلحات موضوعية: Adult, Male, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Blotting, Western, Adenocarcinoma, Receptor, IGF Type 1, Immunoenzyme Techniques, Growth factor receptor, Carcinoma, Non-Small-Cell Lung, Internal medicine, Biomarkers, Tumor, medicine, Humans, Epidermal growth factor receptor, Lung cancer, Receptor, Aged, Neoplasm Staging, Retrospective Studies, Insulin-like growth factor 1 receptor, Aged, 80 and over, Frozen section procedure, biology, business.industry, Middle Aged, Prognosis, medicine.disease, ErbB Receptors, Survival Rate, body regions, stomatognathic diseases, Tissue Array Analysis, Carcinoma, Squamous Cell, biology.protein, Carcinoma, Large Cell, Biomarker (medicine), Immunohistochemistry, Female, Neoplasm Grading, Neoplasm Recurrence, Local, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d79844b56457105c08e1247f33e7d2bTest
https://doi.org/10.1016/j.cllc.2013.08.005Test

المؤلفون: Eloisa Jantus-Lewintre, Carlos Camps, Vega Iranzo, Sara Blasco, Ana Blasco, Roy M. Bremnes, Rafael Sirera, Alfonso Berrocal, Miquel Taron, Nieves del Pozo, Rafael Rosell, Cristina Caballero

المصدر: RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname

مصطلحات موضوعية: Drug dose regimen, Male, Cancer Research, Lung Neoplasms, Unclassified drug, DNA Repair, medicine.medical_treatment, Docetaxel, NSCLC, XRCC3 protein, Treatment response, Gastroenterology, Efficacy, Efficacy to therapy, Advanced disease, Xeroderma pigmentosum group D protein 23, Multiple cycle treatment, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Medicine, Overall survival, Hazard ratio, Middle Aged, Excision repair cross complementing protein 1, Prognosis, DNA-Binding Proteins, Survival Rate, Treatment Outcome, Oncology, Lung non small cell cancer, Drug dose reduction, Carcinoma, Squamous Cell, Female, Taxoids, medicine.drug, Human, Pulmonary and Respiratory Medicine, Adult, medicine.medical_specialty, Neutropenia, SNP, DNA repair, Adenocarcinoma, Article, Xeroderma pigmentosum group D protein 10, Internal medicine, Advanced cancer, Xeroderma pigmentosum group D protein, Chemotherapy, Humans, Lung cancer, Survival rate, Drug induced disease, Aged, Neoplasm Staging, Retrospective Studies, Xeroderma Pigmentosum Group D Protein, Chemotherapy induced neutropenia, Polymorphism, Genetic, business.industry, Retrospective cohort study, MICROBIOLOGIA, medicine.disease, Sex difference, Endonucleases, Gene frequency, Surgery, Cancer combination chemotherapy, Single nucleotide polymorphism, Drug efficacy, Carcinoma, Large Cell, Cisplatin, business, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87be16a971afd4e0ed51d323d7181596Test
https://pubmed.ncbi.nlm.nih.gov/21726821Test